Coronary spasm, a pathogenic trigger of vulnerable plaque rupture

Chinese Medical Journal

Volumn 124, Issue 23, 2011, Pages 4071-4078

  Wang, Li Xin ^a   Lü, Shu Zheng ^a   Zhang, Wei Jun ^a   Song, Xian Tao ^a   Chen, Hui ^b   Zhang, Li Jie ^a  

^a CAPITAL MEDICAL UNIVERSITY   (China)

^b CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

Coronary spasm; Pathogenic trigger; Vulnerable plaque rupture

Indexed keywords

ARTERY OCCLUSION; ATHEROSCLEROTIC PLAQUE; BLOOD VESSEL REACTIVITY; CIRCADIAN RHYTHM; CLINICAL FEATURE; CORONARY ARTERY SPASM; DISEASE ASSOCIATION; ENDOTHELIAL DYSFUNCTION; EROSION; HUMAN; INFLAMMATION; MECHANICAL STRESS; NONHUMAN; PATHOGENESIS; PATHOLOGICAL ANATOMY; PLAQUE EROSION; PLAQUE MORPHOLOGY; PLAQUE RUPTURE; REVIEW; RUPTURE; SUPERSENSITIVITY; THROMBOCYTE ACTIVATION; THROMBOCYTE AGGREGATION; VULNERABLE PLAQUE;

CORONARY VASOSPASM; HUMANS; PLAQUE, ATHEROSCLEROTIC;

EID: 84862969051     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: 10.3760/cma.j.issn.0366-6999.2011.23.041     Document Type: Review

References (66)

1. Naghavi M, Libby P, Falk E, Casscells W, Litovsky S, Rumberger J, et al. From vulnerable plaque to vulnerable patient: A call for new definitions and risk assessment strategies: Part I. Circulation 2003; 108: 1664-1672.
2. Drakopoulou M, Toutouzas K, Stefanadi E, Tsiamis E, Tousoulis D, Stefanadis C, et al. Association of inflammatory markers with angiographic severity and extent of coronary artery disease. Atherosclerosis 2009; 206: 335-339.
3. Virmani R, Burke AP, Farb Aand Kolodgie FD. Pathology of the vulnerable plaque. JACC 2006; 47(Suppl C): C13-C18.
4. Virmani R, Kolodgie FD, Burke AP, Farb A. Lessons fromden coronary death: a comprehensive morphological classification scheme for atherosclerotic lesions. Arterioscl Throm Vas 2000; 20: 1262-1275.
5. Kolodgie FD, Burke AP, Farb A, Kolodgie FD, Farb A. The thin-cap fibroatheroma: a type of vulnerable plaque: the major precursor lesion to acute coronary syndromes. Curr Opin Cardiol 2001; 16: 285-292.
6. Yasue H, Nakagawa H, Itoh T, Harada E, Mizuno Y. Coronary artery cinical features, diagnosis, pathogenesis, and treatment. J Cardiol 2008; 51: 2-17.
7. Yasue H, Sasayama S, Kikuchi K, Okumura K, Matsubara T, Miwa K, et al. The study on the role of coronary spasm inischemic heart disease. In: Annual report of the research on cardiovascular diseases. Osaka: National Cardiovascular Center; 2000: 96-97.
8. Maseri A, Davies G, Hackett D, Kaski JC. Coronary artery spasm and vasoconstriction. The case for a distinction. Circulation 1990; 81: 1983-1991.
9. Luscher TF, Pepine CJ. Coronary spasm and atherothrombosis. In: Fuster V, Ross R, Topol EJ, Nabel EG, eds. Atherothrombosis and coronary artery disease. 2nd ed. Philadelphia & New York: Lipincott-Raven; 2005: 599-621.
10. asue H, Omote S, Takizawa A, Nagao M, Miwa K, Tanaka S. Coronary arterial spasm in ischemic heart disease and its pathogenesis. A review. Circ Res 1983; 52 (Suppl I):147-159.
11. Virmani R, Burke A, Farb A, Kolodgie FD. Pathology of the vulnerable plaque. J Am Coll Cardiol 2006; 47: C13-C18.
12. Hao H, Gabbiani G, Camenzind E, Bacchetta M, Virmanil R, Bochato-Piallat ML. Phenotypic modulation of intima and medial smooth muscle cells in fatal cases of coronary artery lesions. Arterioscl Throm Vas 2006; 26: 326-332.
13. Mizuno Y, Yasue H, Harada E. Effects of statins on coronary artery spasm using quantitative coronary analysis. Circulation 2007; 116 (Suppl II): 562.
14. Stanley K. Coronary artery spasm: multiple causes and multiple roles in heart disease. Biochem Pharmacol 1995; 49: 859-871.
15. Little WC, Constantinescu M, Applegate RJ, Kutcher MA, Burrows MT, Kahl FR, et al. Can coronary angiography predict the site of a subsequent myocardial infarction in patients with mild-to-moderate coronary artery disease? Circulation 1988; 78: 1157-1166.
16. Saner HE. The disease-free wall in coronary atherosclerosis. J Am Coll Cardiol 1985; 6: 1096-1099.
17. Richardson RD, Davies MJ, Born GVR. Influence of plaque configuration and stress distribution on fissuring of coronary atherosclerotic plaques. Lancet 1989; 2: 941-944.
18. Davies MJ. Macroscopic or microscopic view of coronary thrombi. Circulation 1990; 82: 1138-1146.
19. Badimon L, Badimon JJ, Turitto VT, Fuster V. Platelet thrombus formation on collagen type 1: a model of deep vessel injury: influence of blood rheology, von Willebrand factor, and blood coagulation. Circulation 1988; 78: 1432-1442.
20. Yasue H, Kugiyama K. Coronary spasm: clinical features and pathogenesis. Intern Med 1997; 36: 760-765.
21. Willich SN, Linderer T, Wegscheider K, Schroder R; The ISAM Study Group. Increased risk of myocardial infarction in the morning. J Am Coll Cardiol 1988; 11: 28A.
22. Masuda T, Yasue H, Ogawa H, Misumi I, Sakamoto T, Okubo H, et al. Plasma plasminogen activator inhibitor activity and tissue plasminogen activator levels in patients with unstable angina and those with coronary spastic angina. Am Heart J 1992; 124: 314-319.
23. Libby P. Current concepts of the pathogenesis of the acute coronary syndromes. Circulation 2001; 104: 365-372.
24. Richardson PD, Davies MJ, Born GV. Influence of plaque configuration and stress distribution on fissuring of coronary atherosclerotic plaque. Lancet 1989; 2: 941-944.
25. Falk E. Plaque rupture with severe pre-existing stenosis precipitating coronary thrombosis: characteristics of coronary atherosclerotic plaque underlying fatal occlusive thrombi. Br Heart J 1983; 50: 127-134.
26. Fischer GM, Swain ML, Cherian K. Increased vascular collagen and elastin synthesis among major vessels. Atherosclerosis 1980; 35: 11-20.
27. Lee RT, Grodzinsky AJ, Frank EH, Kamm RD, Schoen FJ. Structure-dependent dynamic mechanical behavior of fibrous caps from human atherosclerotic plaques. Circulation 1991; 83: 1764-1770.
28. Cheng C, Tempel D, Haperen R, Baan A, Grosveld F, Daemen M, et al. Atherosclerotic lesion size and vulnerablility are determined by patterns of fluid shear stress. Circulation 2006; 113: 2744-2753.
29. Hellstrom HR. Evidence in favor of the vasospastic cause of coronary artery thrombosis. Am Heart J 1979; 97: 449-452.
30. Factor SM, Cho S. Smooth muscle contraction bands in the media of coronary arteries: A postmortem marker of antemortem coronary spasm. J Am Coll Cardiol 1985; 6: 1329-1337.
31. Joris I, Majno G. Endothelial changes induced by arterial spasm. Am J Pathol 1981; 102: 346-358.
32. Morimoto SI, Shiga Y, Hiramitsu S, Yamada K, Nomura S, Miyagi Y, et al. Plaque rupture possibly induced by coronary spasm. Jpn Circ J 1988; 52: 1286-1292.
33. Lin CS, Penda PD, Zak FG, Lin JC. Morphodynamic interpretation of acute coronary thrombosis, with special reference to volcano-like eruption of artheromatous plaquecaused by coronary artery spasm. Angiology 1988; 39:535-547.
34. Tousoulis D, Davies G, McFadden E, Clarke J, Kaski JC, Maseri A. Coronary vasomotor effects of serotonin in patients with angina. Circulation 1993; 88: 1518-1526.
35. Quinn MT, Parthasarathy S, Fong LG, Steinberg D. Oxidatively modified low density lipoproteins: a potential role in recruitment and retention of monocyte/macrophages during atherohenesis. Proc Natl Acad Sci USA 1987; 84: 2995-2998.
36. Visse R, Nagase H. Matrix metalloproteinases and tissue inhibitors of metalloproteinases: structure, function, and biochemistry. Circ Res 2003; 92: 827-839.
37. Chase AJ, Newby AC. Regulation of matrix metalloproteinases (matrixin) genes in blood vessels: a multi-step recruitment model for pathological remodeling. J Vasc Res 2003; 40: 329-343.
38. Herman MP, Sukhova GK, Libby P, Gerdes N, Tang NG, Horton DB, et al. Expression of neutrophil collagenases (matrix metalloproteinases-8) in human atheroma: a novel collagenolytic pathway suggested by transcriptional profiling. Circulation 2001; 104: 1899-1904.
39. Li JJ, Nie SP, Xu B, Guo YL, Gao Z, Zheng X. Inflammation in variant angina: is there any evidence? Med Hypotheses 2007; 68: 635-640.
40. Kovanen PT, Kaartinen M, Paavone T. Infiltrates of activated mast cells at the site of coronary atheromatous erosion or rupture in myocardial infraction. Circulation 1995; 92: 1084-1088.
41. Forman MB, Oates JA, Robertson D, Robertson RM, Roberts LJ, Virmani R. Increased adventitial mast cells in patients with coronary spasm. N En gl J Med 1985; 313: 1138-1141.
42. Hung MJ, Cherng WJ, Yang NI, Cheng CW, Li LF. Relation of high-sensitivity C-reactive protein level with coronary vasospastic angina pectoris in patients without hemodynamically significant coronary artery disease. Am J Cardiol 2005; 96: 1484-1490.
43. Itoh T, Mizuno Y, Harada E, Yoshimura M, Ogawa H, Yasue H, et al. Coronary spasm is associated with chronic low-grade inflammation. Circ J 2007; 71: 1074-1078.
44. Suzuki H, Kawai S, Aizawa T, Kato K, Sunayama S, Okada R, et al. Histological evaluation of coronary plaque in patients with variant angina. relationship between vasospasm and neointimal hyperplasia in primary coronary lesions. J Am Coll Cardiol 1999; 33: 198-205.
45. Murad F. Nitric oxide and cyclic GMP in cell signaling and drug development. N Engl J Med 2006; 355: 2003-2011.
46. Vita JA, Treasure CB, Nabel EG, McLenachan JM, Fish RD, Yeung AC, et al. Coronary vasomotor response to acetylcholine relates to risk factors for coronary artery disease. Circulation 1990; 81: 491-497.
47. Thom S, Hughes A, Sever PS. Endothelium-dependent response in human arteries. In: Relaxing and contractingfactor. Biological and clinical research, Vanhoutte PMed. Clifton: Humana Press; 1988: 511-528.
48. Zeiher AM, Drexler H, Saurbier B, Just H.Endothelium-mediated coronary blood flow modulation in humans. Effects of age, atherosclerosis, hypercholesterolemia and hypertension. J Clin Invest 1993; 92: 652-662.
49. Pascual R, Bevan JA. Asymmetry of consequences of drug disposition mechanisms in the wall of the rabbit aorta. Circ Res 1980; 46: 22-28.
50. Folts JD, Crowell EB, Rowe GG. Platelet aggregation in partially obstructed vessels and its elimination with aspirin. Circulation 1976; 54: 365-370.
51. Bertha BG, Folts JD. Inhibition of epinephrine-exacerbated coronary thrombus formation by prostacyclin in the dog. J Lab Clin Med 1984; 103: 204-214.
52. Willerson JT, Eidt JF, McNatt J, Yao SK, Golino P, Anderson HV, et al. Role of thromboxane and serotonin as mediators in the development of spontaneous alterations in coronary blood flow and neointimal proliferation in canine models withchronic coronary artery stenoses and endothelial injury. J Am Coll Cardiol 1991; 17: 101B-110B.
53. Davies MJ. Stability and instability: the two faces of coronary atherothrombosis. Circulation 1996; 94: 2013-2020.
54. Kalsner S. Cholinergic mechanisms in human coronary artery preparations: Implications of species differences. J Physiol 1985; 358: 509-526.
55. Biamino G, Kruckenberg P. Synchronization and conduction of excitation in the rat aorta. Am J Physiol 1969; 217:376-382.
56. Spray DC, White RL, Mazet F, Bennett MV. Regulation of gap junctional conductance. Am J Physiol 1985; 248:H753-H764.
57. Somlyo AP, Somlyo AV. Signal transduction and regulation in smooth muscle. Nature 1994; 372: 231-236.
58. Kimura K, Ito M, Amano M, Fukata Y, Chihara K, Nakano T, et al. Regulation of myosin phosphorylation by Rho and Rho-associated kinase (Rho kinase). Science 1996; 273: 245-248.
59. Kalsner S. The effects of periarterial nerve activation on coronary vessel tone in an isolated and perfused slab of beef ventricle. Can J Physiol Pharmacol 1979; 57: 291-297.
60. Theroux P, Waters DD, Affaki GS, Crittin J. Provocative testing with ergonovine to evaluate the efficacy of treatment with calcium antagonists in variant angina. Circulation 1979;60: 504-510.
61. Maseri A, Davies G, Hackett D, Kaski JC. Coronary artery spasm and vasoconstriction. Circulation 1990; 81: 1983-1990.
62. Somlyo AP, Somlyo AV. Ca2+ sensitivity of smooth muscle and nonmuscle myosin II: Modulated by G proteins, kinases, and myosin phosphatase. Physiol Rev 2003; 83: 1325-1358.
63. Shimokawa H, Takeshita A. Rho-kinase is an important therapeutic target in cardiovascular medicine. Arterioscl Throm Vas 2005; 25: 1767-1775.
64. Nakamura M, Takeshita A, Nose Y. Clinical characteristics associated with myocardial infarction, arrhythmias, and sudden death in patients with vasospastic angina. Circulation 1987; 75: 1110-1116.
65. Allen SP, Dashwood MR, Chester AH, Tadjkarimi S, Collins M, Piper P, et al. Influence of atherosclerosis on the vascular reactivity of isolated human epicardial coronary arteries to leukotrience C4. Cardioscience 1993; 4: 47-54.
66. Kalsner S. Coronary artery spasm and no spasmogens? Med Hypotheses 1993; 40: 186-195.